Centogene (NASDAQ:CNTG – Get Rating) was the target of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 31,700 shares, a decrease of 30.5% from the April 15th total of 45,600 shares. Currently, 1.1% of the shares of the company are short sold. Based on an average daily volume of 12,100 shares, the days-to-cover ratio is presently 2.6 days.
NASDAQ:CNTG remained flat at $$3.37 during trading hours on Tuesday. The company’s stock had a trading volume of 171 shares, compared to its average volume of 7,699. The company has a 50-day moving average price of $3.78 and a 200-day moving average price of $5.04. Centogene has a 1 year low of $3.04 and a 1 year high of $11.95.
Centogene (NASDAQ:CNTG – Get Rating) last released its quarterly earnings data on Thursday, March 31st. The company reported ($0.58) earnings per share (EPS) for the quarter. Centogene had a negative return on equity of 98.72% and a negative net margin of 24.23%. The business had revenue of $49.06 million during the quarter. Sell-side analysts anticipate that Centogene will post -1.9 EPS for the current fiscal year.
Separately, Zacks Investment Research upgraded Centogene from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 25th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $18.75.
Centogene Company Profile (Get Rating)
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- Walmart’s “Everyday Low Prices” Gets Burned By Inflation
- VMWare Inc: Strong Revenues and Excellent Potential
- Beware The Rebound In Home Depot
- Time to Ride These 3 Mid Cap Momentum Plays
- Etsy Buy!: Why Etsy Stock is Making a Crafty Comeback
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.